Delivery Order SPE2DB24D2010-SPE2DB25FZXR2
Award Date
4/15/25
Potential Completion Date
4/16/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order valued at $7,949.34 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a period of performance through June 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The delivery order is valued at $1,456.32 and has a completion date of June 8, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $5,290.90 for the supply of Cyclosporine 0.05% eye emulsion. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 20, 2024. The IDC held by Amerisourcebergen with the DLA Troop Support Medical is valued at $999,999,999 and runs through November 2026,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty medication, with a ceiling value of $1,088.96 and a period of performance through February 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion 60s, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,546.26 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 17, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Cyclosporine 0.05% eye emulsion. The $1,611.54 firm fixed-price delivery order has a completion date of January 18, 2023 and was awarded on January 17, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,137.33 firm fixed-price delivery order is for the supply of 60 units of 0.05% cyclosporine eye emulsions. The contract has an ultimate completion date of May 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a critical ophthalmic medication, to support military treatment facilities and other government healthcare programs. The contract has a firm fixed price of $2,991.65 and runs through September 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with...
This federal contract award is for $7,424.52 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, which serves as a primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,279.87, is a delivery order for the supply of cyclosporine 0.05% eye emulsion. The contract has an ultimate completion date of May 30, 2023 and is a firm fixed-price, non-set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...